Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03059147
Title A Study of Single Agent SF1126 Inhibitor in Patients With Advanced Hepatocellular Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors SignalRX Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field